187 related articles for article (PubMed ID: 17726462)
1. Prevalence of human papillomavirus antibodies in young female subjects in England.
Jit M; Vyse A; Borrow R; Pebody R; Soldan K; Miller E
Br J Cancer; 2007 Oct; 97(7):989-91. PubMed ID: 17726462
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pandeya N; Pawlita M; Waterboer T; Neale RE
Virology; 2010 Nov; 407(1):26-32. PubMed ID: 20723959
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
4. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
5. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.
Heiligenberg M; Michael KM; Kramer MA; Pawlita M; Prins M; Coutinho RA; Dukers-Muijrers NH; Waterboer T
Sex Transm Dis; 2010 Nov; 37(11):672-80. PubMed ID: 20729796
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human papillomavirus type 16 in children.
Dunne EF; Karem KL; Sternberg MR; Stone KM; Unger ER; Reeves WC; Markowitz LE
J Infect Dis; 2005 Jun; 191(11):1817-9. PubMed ID: 15871113
[TBL] [Abstract][Full Text] [Related]
10. Frequency of antibodies against E4 and E7 from human papillomavirus type 16 in Mexican soldiers.
Plett-Torres T; Cruz-Valdez A; Esquivel-Guadarrama F; Hernández-Nevarez P; Lazcano-Ponce E; Gutiérrez-Xicotencatl L
Arch Virol; 2007 Jan; 152(1):97-114. PubMed ID: 16896549
[TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
[TBL] [Abstract][Full Text] [Related]
12. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls.
Cubie HA; Plumstead M; Zhang W; de Jesus O; Duncan LA; Stanley MA
J Med Virol; 1998 Nov; 56(3):210-6. PubMed ID: 9783687
[TBL] [Abstract][Full Text] [Related]
13. Detection of HPV types and neutralizing antibodies in Gansu province, China.
Wu X; Zhang C; Feng S; Liu C; Li Y; Yang Y; Gao J; Li H; Meng S; Li L; Zhang Y; Hu X; Wu X; Lin L; Li X; Wang Y
J Med Virol; 2009 Apr; 81(4):693-702. PubMed ID: 19235880
[TBL] [Abstract][Full Text] [Related]
14. Age-specific HPV seroprevalence among young females in The Netherlands.
Kramer M; Mollema L; Smits G; Boot H; de Melker H; van der Klis F
Sex Transm Infect; 2010 Dec; 86(7):494-9. PubMed ID: 20519252
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.
Vaccarella S; Franceschi S; Clifford GM; Touzé A; Hsu CC; de Sanjosé S; Pham TH; Nguyen TH; Matos E; Shin HR; Sukvirach S; Thomas JO; Boursaghin L; Gaitan J; Snijders PJ; Meijer CJ; Muñoz N; Herrero R; Coursaget P;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2379-88. PubMed ID: 20826835
[TBL] [Abstract][Full Text] [Related]
16. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.
Clifford GM; Shin HR; Oh JK; Waterboer T; Ju YH; Vaccarella S; Quint W; Pawlita M; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1874-9. PubMed ID: 17855708
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
18. Review: antibodies to cutaneous human papillomaviruses.
Antonsson A
J Med Virol; 2012 May; 84(5):814-22. PubMed ID: 22431031
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of seven high-risk HPV types in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
[TBL] [Abstract][Full Text] [Related]
20. Type-specific antiviral antibodies to genital human papillomavirus types in mothers and newborns.
Heim K; Hudelist G; Geier A; Szedenik H; Christensen ND; Concin N; Bergant A; Volgger B; Czerwenka K; Höpfl R
Reprod Sci; 2007 Dec; 14(8):806-14. PubMed ID: 18089599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
